The Elixir Factor podcast brings researchers together with industry leaders, advocacy groups, patients, and their loved ones to discuss how Lilly tackles the world’s most significant health challenges. Tune in as we unpack complex science and innovative breakthroughs that can make life better for people around the world.
S4 Ep12: Inspiring Better Dialogues in UC Care – The CONFIDE Study
S4 Ep11: Treating Untreatable Diseases with Genetic Medicine
S4 Ep10: Redefining Innovation with Gateway Labs by Lilly: A Look Inside the Accelerator Experience
S4 Ep9: A Clearer Approach to Clinical Trials in Atopic Dermatitis for People with Skin of Color
S4 Ep8: Future of Clinical Trials with Continuous Patient Monitoring – Part 2
As Lilly delivers medicines with speed and purpose, patient safety during clinical trials remains one of Lilly’s top priorities. This week, we welcome back our host Brian Winger, Lilly’s Associate Vice President, Digital Health Research and Development, Xiangnan Dang, Director of Engineering, and guests from Part 1, Tony Fantana and Chuck Benson. Guests on this episode will dive into the uniqueness of this technology; its effects and benefits to clinical trials; and, what’s next for Lilly in the future of clinical trials and monitoring for patient safety.
S4 Ep7: Utilizing Technology to Monitor Patient Safety and Improve Patient Experience in Clinical Trials – Part 1
I just listened to Episode 7 regarding the advancement of technology and innovation in managing Type 1 diabetes. The guests provide eye-opening insights into the personal struggles those with the disease face 24-hours a day for life. It’s fascinating to hear about the human drive to bridge the gap in understanding of technological limitations (and possibilities) between patients and researchers.
Joe is amazing
Have been a big fan of Joe’s work through out the years and listening to him via this podcast is icing on the cake ! Wishing Joe the very best